BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10885223)

  • 1. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
    Paul C; Hast R
    Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
    Möhle R; Kanz L
    Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic use of hematopoietic growth factors.
    Costa JJ
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
    [No Abstract]   [Full Text] [Related]  

  • 4. Are guidelines on use of colony-stimulating factors in solid cancers flawed?
    Haines IE; Olver I
    Intern Med J; 2009 Apr; 39(4):259-62. PubMed ID: 19402867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic growth factors in cancer chemotherapy.
    Lieschke GJ; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1997; 17():363-89. PubMed ID: 9551221
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of hematopoietic growth factors in transfusion medicine.
    Goodnough LT
    Curr Opin Hematol; 1994 Nov; 1(6):462-70. PubMed ID: 9371324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
    Moreno García M; Fernández González F
    Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of leukomax (granulocyte-macrophage colony stimulating factor) in oncology and hematology].
    Gorbunova VA
    Vopr Onkol; 1995; 41(1):21-8. PubMed ID: 7667936
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic potential of the hematopoietic growth factors.
    Usha D; Thatte UM; Dahanukar SA
    J Postgrad Med; 1994; 40(4):210-5. PubMed ID: 9136242
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost effectiveness of myeloid growth factors in cancer chemotherapy.
    Lyman GH; Kuderer NM
    Curr Hematol Rep; 2003 Nov; 2(6):471-9. PubMed ID: 14561391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of hematopoietic growth factors].
    Krusius T
    Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor: present use and future directions.
    Shadduck RK
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):38-42. PubMed ID: 1492233
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factors: finding the right indication.
    Lyman GH; Shayne M
    Curr Opin Oncol; 2007 Jul; 19(4):299-307. PubMed ID: 17545791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic growth factors in cancer chemotherapy.
    Crawford J; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1999; 18():250-67. PubMed ID: 10800487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS; Roboz GJ
    Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Foote M; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.
    Satwani P; Bessmertny O; Morris E; Cairo MS
    Curr Hematol Rep; 2003 Nov; 2(6):480-90. PubMed ID: 14561392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

  • 20. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective.
    Bargetzi MJ; Passweg J; Baertschi E; Schoenenberger A; Gwerder C; Tichelli A; Burger J; Mingrone W; Herrmann R; Gratwohl A; Wernli M
    Bone Marrow Transplant; 2003 Jan; 31(2):99-103. PubMed ID: 12621490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.